• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞色素P-450酶介导的基因多态性和药物相互作用的临床意义。

Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes.

作者信息

Touw D J

机构信息

Department of Pharmacy, University Hospital Vrije Universiteit, Amsterdam, The Netherlands.

出版信息

Drug Metabol Drug Interact. 1997;14(2):55-82.

PMID:9893738
Abstract

Hepatic oxidation is a major drug metabolising process and is carried out by the cytochrome P-450 monooxygenase system. This system consists of a variety of isoenzymes among which the cytochromes 1A2, 2C8, 2C9/10, 2C19, 2D6, 2E1 and 3A4 are involved in the oxidative metabolism of drugs. Interindividually, large differences in capacities are found. These differences are partly due to genetic constitution (genetic polymorphism, which has been proved to exist for CYP2D6 and CYP2C19) and partly due to environmental factors, among which the administration of interfering drugs can play a major role.

摘要

肝脏氧化是主要的药物代谢过程,由细胞色素P-450单加氧酶系统执行。该系统由多种同工酶组成,其中细胞色素1A2、2C8、2C9/10、2C19、2D6、2E1和3A4参与药物的氧化代谢。个体之间存在很大的能力差异。这些差异部分归因于遗传构成(遗传多态性,已证明CYP2D6和CYP2C19存在遗传多态性),部分归因于环境因素,其中干扰药物的使用可能起主要作用。

相似文献

1
Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes.细胞色素P-450酶介导的基因多态性和药物相互作用的临床意义。
Drug Metabol Drug Interact. 1997;14(2):55-82.
2
Polymorphism of human cytochrome P450 enzymes and its clinical impact.人类细胞色素P450酶的多态性及其临床影响。
Drug Metab Rev. 2009;41(2):89-295. doi: 10.1080/03602530902843483.
3
Heterologous expression and kinetic characterization of human cytochromes P-450: validation of a pharmaceutical tool for drug metabolism research.人细胞色素P-450的异源表达及动力学特性:药物代谢研究中一种药学工具的验证
Drug Metab Dispos. 1999 Oct;27(10):1117-22.
4
The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.人细胞色素P-450同工酶对哌嗪型吩噻嗪类抗精神病药奋乃静的代谢作用。
Eur Neuropsychopharmacol. 2004 May;14(3):199-208. doi: 10.1016/S0924-977X(03)00105-6.
5
Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s.由主要的人体药物代谢细胞色素P450实现的药物氧化酶学的自动化定义。
Drug Metab Dispos. 2000 Nov;28(11):1327-34.
6
Drug metabolism and drug interactions in the elderly.老年人的药物代谢与药物相互作用
Best Pract Res Clin Gastroenterol. 2001 Dec;15(6):897-918. doi: 10.1053/bega.2001.0249.
7
The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.细胞色素P450代谢对药物反应、相互作用及不良反应的影响。
Am Fam Physician. 2007 Aug 1;76(3):391-6.
8
Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.人细胞色素 P450 酶功能改变所致的多态代谢。
Arch Pharm Res. 2011 Nov;34(11):1799-816. doi: 10.1007/s12272-011-1103-2. Epub 2011 Dec 3.
9
Cytochrome P450-mediated metabolism in the human gut wall.细胞色素P450介导的人体肠壁代谢。
J Pharm Pharmacol. 2009 May;61(5):541-58. doi: 10.1211/jpp/61.05.0002.
10
Bioequivalence revisited: influence of age and sex on CYP enzymes.再谈生物等效性:年龄和性别对细胞色素P450酶的影响
Clin Pharmacol Ther. 2004 Dec;76(6):618-27. doi: 10.1016/j.clpt.2004.08.021.

引用本文的文献

1
Hydroxychloroquine and Potential Drug Interactions in Older Adults.羟氯喹与老年人潜在的药物相互作用
Arch Bronconeumol (Engl Ed). 2020 Oct;56(10):679-681. doi: 10.1016/j.arbr.2020.06.002. Epub 2020 Oct 1.
2
Pharmacomicrobiomics: a novel route towards personalized medicine?药物微生物组学:迈向个体化医学的新途径?
Protein Cell. 2018 May;9(5):432-445. doi: 10.1007/s13238-018-0547-2. Epub 2018 Apr 28.
3
Psychiatric diseases: Need for an increased awareness among the anesthesiologists.精神疾病:麻醉医生需提高认识。
J Anaesthesiol Clin Pharmacol. 2011 Oct;27(4):440-6. doi: 10.4103/0970-9185.86572.
4
Extreme bradycardia due to multiple drug-drug interactions in a patient with HIV post-exposure prophylaxis containing lopinavir-ritonavir.一名接受含洛匹那韦-利托那韦的HIV暴露后预防治疗的患者,因多种药物相互作用导致严重心动过缓。
Br J Clin Pharmacol. 2011 Apr;71(4):621-3. doi: 10.1111/j.1365-2125.2010.03849.x.
5
Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole.CYP2C19、MDR1 和白细胞介素 1-B 基因变异对泮托拉唑、阿莫西林和甲硝唑三联疗法根除幽门螺杆菌感染的影响。
Eur J Clin Pharmacol. 2010 Jul;66(7):681-7. doi: 10.1007/s00228-010-0818-1. Epub 2010 Apr 8.
6
Management of postoperative nausea and vomiting: focus on palonosetron.术后恶心呕吐的管理:以帕洛诺司琼为重点。
Ther Clin Risk Manag. 2009 Feb;5(1):21-34. Epub 2009 Mar 26.
7
Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting.细胞色素P450同工酶2C9、2C19和2D6多态性对自然临床环境中抗抑郁药血浆浓度及临床效果的影响。
Eur J Clin Pharmacol. 2004 Jul;60(5):329-36. doi: 10.1007/s00228-004-0766-8. Epub 2004 May 28.
8
Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.质子泵抑制剂的临床药理学:执业医师需要了解的内容。
Drugs. 2003;63(24):2739-54. doi: 10.2165/00003495-200363240-00004.
9
Pharmacogenomics: the promise of personalized medicine.药物基因组学:个性化医疗的前景。
AAPS PharmSci. 2000;2(1):E4. doi: 10.1208/ps020104.
10
Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: structural identification, levels in plasma, and antiviral activities.人免疫缺陷病毒蛋白酶抑制剂奈非那韦在人体内的循环代谢产物:结构鉴定、血浆水平及抗病毒活性
Antimicrob Agents Chemother. 2001 Apr;45(4):1086-93. doi: 10.1128/AAC.45.4.1086-1093.2001.